Role, metabolism, chemical modifications and applications of hyaluronan

Current Medicinal Chemistry

Volumn 16, Issue 14, 2009, Pages 1718-1745

  Volpi, Nicola ^a   Schiller, Juergen ^b   Stern, Robert ^c   Šoltés, Ladislav ^d  

^a UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^b UNIVERSITY OF LEIPZIG   (Germany)

^c AL QUDS UNIVERSITY   (Palestine)

^d INSTITUTE OF EXPERIMENTAL PHARMACOLOGY AND TOXICOLOGY   (Slovakia)

Author keywords

Glycosaminoglycans; Hyaluronan or hyaluronic acid

Indexed keywords

ABC TRANSPORTER; AGENTS ACTING ON THE EYE; CELL ADHESION MOLECULE; EUFLEXXA; HYALURONAN SYNTHASE; HYALURONAN SYNTHASE 2; HYALURONIC ACID; HYALURONIDASE; HYALURONIDASE 1; HYALURONIDASE 2; HYALURONIDASE 3; HYALURONIDASE 4; HYDROGEN PEROXIDE; HYDROXYL GROUP; HYPOCHLOROUS ACID; MULTIDRUG RESISTANCE PROTEIN 1; MULTIDRUG RESISTANCE PROTEIN 5; NITRIC OXIDE; REACTIVE OXYGEN METABOLITE; SINGLET OXYGEN; SPERM ADHESION MOLECULE 1; STEROID; SUPEROXIDE; SYNTHETASE; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG; HYALURONOGLUCOSAMINIDASE;

ANALGESIC ACTIVITY; ANGIOGENESIS; ANTIINFLAMMATORY ACTIVITY; ARTICULAR CARTILAGE; BACTERIOPHAGE; BIOMEDICAL ENGINEERING; BIOSYNTHESIS; CANCER GROWTH; CARTILAGE CELL; CELL ADHESION; CELL INVASION; CELL MIGRATION; CHEMICAL MODIFICATION; CHEMICAL STRUCTURE; EMBRYO DEVELOPMENT; ENDOPLASMIC RETICULUM STRESS; ENZYME DEGRADATION; EXTRACELLULAR SPACE; FERTILIZATION; FIBROBLAST; GENE EXPRESSION; GENE FUNCTION; HUMAN; INFLAMMATION; MALIGNANT TRANSFORMATION; METABOLISM; MITOSIS; MONOCYTE; NEOVASCULARIZATION (PATHOLOGY); NONHUMAN; OSTEOARTHRITIS; OVULATION; PAIN; PROTEIN METABOLISM; PROTEIN PHOSPHORYLATION; PROTEIN TRANSPORT; REVIEW; SIGNAL TRANSDUCTION; STRUCTURE ANALYSIS; SURGICAL INSTRUMENT; SYNOVIAL FLUID; TISSUE LEVEL; TURNOVER TIME; VISCOSITY; ANIMAL; CHEMISTRY; HYDROLYSIS;

ANIMALS; HUMANS; HYALURONIC ACID; HYALURONOGLUCOSAMINIDASE; HYDROLYSIS;

EID: 67651049960     PISSN: 09298673     EISSN: None     Source Type: Journal    
DOI: 10.2174/092986709788186138     Document Type: Review

References (253)

1. Meyer, K.; Palmer, J.W. The polysaccharide of the vitreous humor. J. Biol. Chem., 1934, 107, 629-634.
2. Weissman, B.; Meyer, K. The structure of hyaluronic acid from umbilical cord. J. Am. Chem. Soc., 1954, 76, 1753-1757.
3. Fraser, J.R.E.; Laurent, T.C.; Laurent, U.B.G. Hyaluronan: Its nature, distribution, functions and turnover. J. Intern. Med., 1997, 242, 27-33.
4. Hascall, V.C. Hyaluronan, a common thread. Glycoconj. J., 2000, 17, 607-616.
5. Hascall, V.C.; Majors, A.K.; De La Motte, C.A.; Evanko, S.P.; Wang, A.; Drazba, J.A.; Strong, S.A.; Wight, T.N. Intracellular hyaluronan: A new frontier for inflammation? Biochim. Biophys. Acta, 2004, 1673, 3-12.
6. Kogan, G.; Šoltés, L.; Stern, R.; Gemeiner, P. Hyaluronic acid: A natural biopolymer with a broad range of biomedical and industrial applications. Biotechnol. Lett., 2007, 29, 17-25.
7. Garg, H.G.; Hales, C.A. Chemistry and Biology of Hyaluronan, Elsevier:AMsterdam, 2004.
8. Kogan, G.; Šoltés, L.; Stern, R.; Mendichi, R. Hyaluronic acid: A biopolymer with versatile physico-chemical and biological properties M; In: Handbook of polymer research: monomers, oligomers, polymers and composites. Pethrick, R.A.; Ballada, A.; Zaikov, G.E. (Eds.), 2007, Nova Sci. Publishers, New York.
9. Kogan, G.; Šoltés, L.; Stern, R.; Schiller J.; Mendichi R. Hyaluronic acid: Its function and degradation in in vivo systems. In: Studies in natural products chemistry, 34, Atta-ur-Rahman (Ed.), 2008, Elsevier B.V.; Amsterdam, The Netherlands.
10. Laurent, T.C. The chemistry, biology and medical applications of hyaluronan and its derivatives. 1998, Portland Press, London.
11. Balazs, E.A. The introduction of elastoviscous hyaluronan for viscosurgery. In: Rosen, E.S.; ed. Viscoelastic Materials. Basic Science and Clinical Applications. Oxford, Pergamon Press, 1989. pp. 167-83.
12. Balazs, E.A. Viscoelastic Properties of Hyaluronan and its Therapeutic Use. In: Garg, H.G.; Hales, C.A. (Eds.) Chemistry and Biology of Hyaluronan, 2004, Elsevier B.V.; Amsterdam, The Netherlands.
13. Vercruysse, K.P.; Prestwich, G.D. Hyaluronate derivatives in drug delivery. Crit. Rev. Ther Drug Carrier. Syst., 1998, 15, 513-555.
14. Lapcík, L. Jr.; Lapcík, L.; De Smedt, S.; Demeester, J.; Chabrecek, P. Hyaluronan: Preparation, Structure, Properties, and Applications. Chem. Rev., 1998, 98, 2663-2684.
15. Shiedlin, A.; Bigelow, R.; Christopher, W.; Arbabi, S.; Yang, L.; Maier, R.V.; Wainwright, N.; Childs, A.; Miller, R.J. Evaluation of hyaluronan from different sources: Streptococcus zooepidemicus, rooster comb, bovine vitreous, and human umbilical cord. Biomacromolecules, 2004, 5, 2122-7.
16. Hardingham, T. Solution Properties of Hyaluronan. In: Garg, H.G.; Hales, C.A. (Eds.) Chemistry and Biology of Hyaluronan, 2004, Elsevier B.V.; Amsterdam, The Netherlands.
17. Evanko, S.; Wight, T.N. Intracellular Hyaluronan. In: Hyaluronan: Synthesis, Function, Catabolism. Available at http://glycoforum.gr.jp/ science/hyaluronan/HA20/HA20E.html.
18. Schiller, J.; Fuchs, B.; Arnhold, J.; Arnold, K. Contribution of reactive oxygen species to cartilage degradation in rheumatic diseases: molecular pathways, diagnosis and potential therapeutic strategies. Curr. Med. Chem., 2003, 10, 2123-45.
19. Tammi, M.I.; Day, A.J.; Turley, E.A. Hyaluronan and homeostasis: A balancing act. J. Biol. Chem., 2002, 277, 4581-9
20. DeAngelis, P.L.; Papaconstantinou, J.; Weigel, P.H. Molecular cloning, identification and sequence of the hyaluronan synthase gene from group A Streptococcus pyogenes. J. Biol. Chem., 1993, 268, 19181-4.
21. DeAngelis, P.L.; Papaconstantinou, J.; Weigel, P.H. Isolation of a Streptococcus pyogenes gene locus that directs hyaluronan biosynthesis in acapsular mutants and in heterologous bacteria. J. Biol. Chem., 1993, 268, 14568-71.
22. Philipson, L.H.; Schwartz, N.B. Subcellular localization of hyaluronate synthetase in oligodendroglioma cells. J. Biol. Chem., 1984, 259, 5017-23
23. Prehm, P. Hyaluronate is synthesized at plasma membranes. Biochem. J., 1984, 220, 597-600.
24. Philipson, L.H.; Westley, J.; Schwartz, N.B. Effect of hyaluronidase treatment of intact cells on hyaluronate synthetase activity. Biochemistry, 1985, 24, 7899-906.
25. Larnier, C.; Kerneur, C.; Robert, L.; Moczar, M. Effect of testicular hyaluronidase on hyaluronate synthesis by human skin fibroblasts in culture. Biochim. Biophys. Acta, 1989, 1014, 145-52.
26. [26] Spicer, A.P.; Seldin, M.F.; Olsen, A.S.; Brown, N.; Wells, D.E.; Doggett, N.A.; Itano, N.; Kimata, K.; Inazawa, J.; McDonald, J.A. Chromosomal localization of the human and mouse hyaluronan synthase genes. Genomics, 1997, 41, 493-7.
27. Spicer, A.P.; McDonald, J.A. Characterization and molecular evolution of a vertebrate hyaluronan synthase gene family. J. Biol. Chem., 1998, 273, 1923-32.
28. Reitinger, S.; Müllegger, J.; Lepperdinger, G. Xenopus kidney hyaluronidase-1 (XKH1), a novel type of membrane-bound hyaluronidase solely degrades hyaluronan at neutral pH. FEBS Lett., 2001, 505, 213-6.
29. Lepperdinger, G.; Fehrer, C. and Reitlinger, S. Biodegradation of hyaluronan. In Chemistry and biology of hyaluronan; Gargand HalesEds.; Elsevier Press, Amsterdam, 2004, pp. 71-82.
30. Itano, N.; Kimata, K. Molecular cloning of human hyaluronan synthase, Biochem. Biophys. Res. Commun., 1996, 222, 816-20
31. Weigel, P.H.; Hascall, V.C.; Tammi, M. Hyaluronan synthases. J. Biol. Chem., 1997, 272, 13997-14000.
32. Itano, N.; Sawai, T.; Yoshida, M.; Lenas, P.; Yamada, Y.; Imagawa, M.; Shinomura, T.; Hamaguchi, M.; Yoshida, Y.; Ohnuki, Y.; Miyauchi, S.; Spicer, A.P.; McDonald, J.A.; Kimata, K. Three isoforms of mammalian hyaluronan synthases have distinct enzymatic properties. J. Biol. Chem., 1999, 274, 25085-92.
33. Camenisch, T.D.; Spicer, A.P.; Brehm-Gibson, T.; Biesterfeldt, J.; Augustine, M.L.; Calabro, A. Jr.; Kubalak, S.; Klewer, S.E.; McDonald, J.A. Disruption of hyaluronan synthase-2 abrogates normal cardiac morphogenesis and hyaluronan-mediated transformation of epithelium to mesenchyme. J. Clin. Invest., 2000, 106, 349-60
34. Itano, N.; Sawai, T.; Atsumi, F.; Miyaishi, O.; Taniguchi, S.; Kannagi, R.; Hamaguchi, M.; Kimata K. Selective expression and functional characteristics of three mammalian hyaluronan synthases in oncogenic malignant transformation. J. Biol. Chem., 2004, 279, 18679-87.
35. Ouskova, G.; Spellerberg, B.; Prehm, P. Hyaluronan release from Streptococcus pyogenes: Export by an ABC transporter. Glycobiology, 2004, 14, 931-8.
36. Ashbaugh, C.D.; Wessels, M.R. Identification of a gene similar to ABC transporters near the capsule synthesis region of the group A streptococcal chromosome. Dev. Biol. Stand., 1995, 85:231-5.
37. Prehm, P.; Schumacher, U. Inhibition of hyaluronan export from human fibroblasts by inhibitors of multidrug resistance transporters. Biochem. Pharmacol., 2004, 68, 1401-10.
38. Itano, N.; Kimata, K. Mammalian hyaluronan synthases. IUBMB Life, 2002, 54, 195-9.
39. McDonald, J.A.; Camenisch, T.D. Hyaluronan: Genetic insights into the complex biology of a simple polysaccharide. Glycoconj. J., 2002, 19, 331-9.
40. Yamada, Y.; Itano, N.; Hata, K.; Ueda, M.; Kimata, K. Differential regulation by IL-1beta and EGF of expression of three different hyaluronan synthases in oral mucosal epithelial cells and fibroblasts and dermal fibroblasts: Quantitative analysis using real-time RT-PCR. J. Invest. Dermatol., 2004, 122, 631-9.
41. Spicer, A.P. In vitro assays for Hyaluronan Synthase, in Proteoglycan Protocols, ed. R.V. Iozzo, Humana Press, Totowa, NJ. 2001, p. 373-82.
42. Matuoka, K.; Namba, M.; Mitsui, Y. Hyaluronate synthetase inhibition by normal and transformed human fibroblasts during growth reduction. J. Cell Biol., 1987, 104, 1105-15.
43. Sugiyama, Y.; Shimada, A.; Sayo, T.; Sakai, S.; Inoue, S. Putative hyaluronan synthase mRNA are expressed in mouse skin and TGF-beta upregulates their expression in cultured human skin cells. J. Invest. Dermatol., 1998, 110, 116-21.
44. Kennedy, C.I.; Diegelmann, R.F.; Haynes, J.H.; Yager, D.R. Proinflammatory cytokines differentially regulate hyaluronan synthase isoforms in fetal and adult fibroblasts. J. Pediatr. Surg., 2000, 35, 874-9.
45. Recklies, A.D.; White, C.; Melching, L.; Roughley, P.J. Differential regulation and expression of hyaluronan synthases in human articular chondrocytes, synovial cells and osteosarcoma cells. Biochem J., 2001, 354, 17-24.
46. Asplund, T.; Brinck, J.; Suzuki, M.; Briskin, M.J.; Heldin P. Characterization of hyaluronan synthase from a human glioma cell line Biochim. Biophys. Acta, 1998, 1380, 377-88.
47. Bader, J.P. Temperature-dependent transformation of cells infected with a mutant of Bryan Rous sarcoma virus. J. Virol., 1972, 10, 267-76.
48. Zhang, L.; Underhill, C.B.; Chen, L. Hyaluronan on the surface of tumor cells is correlated with metastatic behavior. Cancer Res., 1995, 55, 428-33.
49. Knudson, W.; Biswas, C.; Toole, B.P. Interactions between human tumor cells and fibroblasts stimulate hyaluronate synthesis. Proc. Natl. Acad. Sci. USA, 1984, 81, 6767-71.
50. Decker, M.; Chiu, E.S.; Dollbaum, C.; Moiin, A.; Hall, J.; Spendlove, R.; Longaker, M.T.; Stern, R. Hyaluronic acid-stimulating activity in sera from the bovine fetus and from breast cancer patients. Cancer Res., 1989, 49, 3499-505.
51. Yabushita, H.; Noguchi, M.; Kishida, T.; Fusano, K.; Noguchi, Y.; Itano, N.; Kimata, K.; Noguchi, M. Hyaluronan synthase expression in ovarian cancer. Oncol. Rep., 2004, 12, 739-43.
52. Yamada, Y.; Itano, N.; Narimatsu, H.; Kudo, T.; Morozumi K.; Hirohashi, S.; Ochiai, A.; Ueda, M.; Kimata, K. Elevated transcript level of hyaluronan synthase1 gene correlates with poor prognosis of human colon cancer. Clin. Exp. Metastasis., 2004, 21, 57-63
53. Liu, N.; Gao, F.; Han, Z.; Xu, X.; Underhill C.B.; Zhang, L. Hyaluronan synthase 3 over expression promotes the growth of TSU prostate cancer cells. Cancer Res., 2001 61, 5207-14.
54. Mian, N. Characterization of a high-Mr plasma-membrane-bound protein and assessment of its role as a constituent of hyaluronate synthase complex. Biochem. J., 1986, 237, 343-57.
55. Mian, N. Analysis of cell-growth-phase-related variations in hyaluronate synthase activity of isolated plasma-membrane fractions of cultured human skin fibroblasts. Biochem. J., 1986, 237, 333-42.
56. Shearer, J.; Graham, T.E. New perspectives on the storage and organization of muscle glycogen. Can. J. Appl. Physiol., 2002, 27, 179-203.
57. DeAngelis, P.L.; Jing, W.; Graves, M.V.; Burbank, D.E.; Van Etten, J.L. Hyaluronan synthase of chlorella virus PBCV-1. Science, 1997, 278, 1800-3.
58. DeAngelis, P.L. Molecular directionality of polysaccharide polymerization by the Pasteurella multocida hyaluronan synthase. J. Biol. Chem., 1999, 274, 26557-62.
59. Meyer, K. Hyaluronidases. In Boyer, P.D. (ed.) The Enzymes, New York, Academic Press, 1971, pp. 307-320.
60. Stern, R.; Jedrzejas, M.J. Hyaluronidases: Their genomics, structures, and mechanisms of action. Chem. Rev., 2006, 106, 818-39.
61. Frost, G.I.; Stern, R. A microtiter-based assay for hyaluronidase activity not requiring specialized reagents. Anal. Biochem., 1997, 251, 263-9.
62. Stern, M.; Stern, R. A collagenous sequence in prokaryotic hyaluronidase. Mol. Biol. Evol., 1992, 9, 1179-80
63. Vigdorovich, V.; Miller, A.D.; Strong, R.K. Ability of hyaluronidase 2 to degrade extracellular hyaluronan is not required for its function as a receptor for jaagsiekte sheep retrovirus. J. Virol., 2007, 81, 3124-9.
64. Rappaport, M.M.; Linker, A.; Meyer, K. The hydrolysis of hyaluronic acid by Pneumococcal hyaluronidase. J. Biol. Chem., 1951, 192, 283-91.
65. Fitzgerald, T.J.; Repesh, L.A. The hyaluronidase associated with Treponema pallidum facilitates treponemal dissemination. Infect. Immun., 1987, 55, 1023-8.
66. Canard, B.; Garnier, T.; Saint-Joanis, B.; Cole, S.T. Molecular genetic analysis of the nagH gene encoding a hyaluronidase of Clostridium perfringens. Mol. Gen. Genet., 1994, 243, 215-24.
67. Abramson, C. Staphylococcal hyaluronate lyase: Multiple electrophoretic and chromatographic forms. Arch. Biochem. Biophys., 1967, 121, 103-6.
68. Duran-Reynals, F. Exaltation de l'activité du virus vaccinal par les extraits de certains Organs. Compt. Rend. Soc. Biol., 1928, 99, 6-7.
69. Duran-Reynals F. Studies on a certain spreading factor exisiting in bacteria and its significance for bacterial invasiveness. J. Exp. Med., 1933, 58. 161-81.
70. Duran-Reynals, F.; Pi, J.S. Exaltation de l'activité du Staphylocoque par les extraits testiculaires. Compt. Rend. Soc. Biol. 1929, 99, 1908-11.
71. Chain, E.; Duthie, E.S. Identity of hyaluronidase and spreading factor. Brit. J. Exp. Path. 1940, 21, 324-38.
72. Frost, G.I.; Csoka, A.B.; Wong, T.; Stern, R. Purification, cloning and expression human plasma hyaluronidase. Biochem. Biophys. Res. Commun. 1997, 236, 10-5.
73. Kreil, G. Hyaluronidases - a group of neglected enzymes. Protein Sci. 1995, 4, 1666-9.
74. Csoka, A.B.; Scherer, S.W.; Stern, R. Expression analysis of six paralogous human hyaluronidase genes clustered on chromosomes 3p21 and 7q31. Genomics. 1999, 60, 356-61.
75. Csoka, A.B.; Frost, G.I, Stern, R. The six hyaluronidase-like genes in the human and mouse genomes. Matrix Biol., 2001, 20, 499-508.
76. Shuttleworth, T.L.; Wilson, M.D.; Wicklow, B.A.; Wilkins, J.A.; Triggs-Raine, B.L. Characterization of the murine hyaluronidase gene region reveals complex organization and cotranscription of Hyal1 with downstream genes, Fus2 and Hyal3. J. Biol. Chem. 2003, 277,23008-18.
77. Lepperdinger, G.; Mullegger, J.; Kreil, G.: Hyal2 - less active, but more versatile? Matrix Biol. 2001, 20, 509-14.
78. Lepperdinger, G.; Strobl, B.; Kreil, G. HYAL2, a human gene expressed in many cells, encodes a lysosomal hyaluronidase with a novel type of specificity. J. Biol. Chem., 1998, 273, 22466-70
79. Atmuri, V.; Martin, D.C.; Hemming, R.; Gutsol, A.; Byers, S, Sahebjam, S.; Thliveris, J.A.; Mort, J.S.; Carmona, E.; Anderson, J.E.; Dakshinamurti, S.; Triggs-Raine, B. Hyaluronidase 3 (HYAL3) knockout mice do not display evidence of hyaluronan accumulation. Matrix Biol., 2008, 27, 653-660.
80. Hemming, R.; Martin, D.C.; Slominski, E.; Nagy, J.I.; Halayko, A.J.; Pind, S.; Triggs-Raine, B. Mouse Hyal3 encodes a 45- to 56-kDa glycoprotein whose over-expression increases hyaluronidase 1 activity in cultured cells. Glycobiology. 2008, 18, 280-9.
81. Cherr, G.N.; Yudin, A.I.; Overstreet, J.W. The dual functions of GPI-anchored PH-20: Hyaluronidase and intracellular signaling. Matrix Biol., 2001, 20, 515-25.
82. Myles, D.G.; Primakoff, P. Why did the sperm cross the cumulus? To get to the oocyte. Functions of the sperm surface proteins PH-20 and fertilin in arriving at, and fusing with, the egg. Biol. Reprod., 1997, 56, 320-7.
83. Deng, X.; He, Y.; Martin-Deleon, P.A. Mouse Spam1 (PH-20): Evidence for its expression in the epididymis and for a new category of spermatogenic-expressed genes. J. Androl., 2000, 21, 822-32.
84. Zhang, H.; Martin-DeLeon, P.A. Mouse Spam1 (PH-20) is a multifunctional protein: Evidence for its expression in the female reproductive tract. Biol. Reprod., 2003, 69, 446-54.
85. Godin, D.A.; Fitzpatrick, P.C.; Scandurro, A.B.; Belafsky, P.C.; Woodworth, B.A.; Amedee, R.G.; Beech, D.J.; Beckman, B.S. PH20: A novel tumor marker for laryngeal cancer. Arch. Otolaryngol. Head Neck Surg., 2000, 12, 402-4.
86. Beech, D.J.; Madan, A.K.; Deng, N. Expression of PH-20 in normal and neoplastic breast tissue. J. Surg. Res., 2002, 103, 203-7.
87. Baba, D.; Kashiwabara, S.; Honda, A.; Yamagata, K.; Wu, Q.; Ikawa, M.; Okabe, M.; Baba, T. Mouse sperm lacking cell surface hyaluronidase PH-20 can pass through the layer of cumulus cells and fertilize the egg. J. Biol. Chem., 2002, 277, 30310-4.
88. Flannery, C.R.; Little, C.B.; Hughes, C.E.; Caterson, B. Expression and activity of articular cartilage hyaluronidases. Biochem. Biophys. Res. Commun., 1998, 251, 824-9.
89. Nicoll, S.B.; Barak, O.; Csóka, A.B.; Bhatnagar, R.S.; Stern, R. Hyaluronidases and CD44 undergo differential modulation during chondrogenesis. Biochem. Biophys. Res. Commun., 2002, 29, 819-25.
90. Miller, A.D. Identification of Hyal2 as the cell-surface receptor for jaagsiekte sheep retrovirus and ovine nasal adenocarcinoma virus. Curr. Top Microbiol. Immunol., 2003 275, 179-99.
91. Fiszer-Szafarz, B. Demonstration of a new hyaluronidase inhibitor in serum of cancer patients. Proc. Soc. Exp. Biol. Med., 1968, 129, 300-2.
92. Mio, K.; Carrette, O.; Maibach, H.I.; Stern, R. Evidence that the serum inhibitor of hyaluronidase may be a member of the interalpha-inhibitor family. J. Biol. Chem., 2000, 275, 32413-21.
93. Stern, R.; Kogan, G.; Jedrzejas, M.J.; Šoltés, L. The many ways to cleave hyaluronan. Biotechnol. Adv., 2007, 25, 537-57.
94. Wientjes, F.B.; Segal, A.W. NADPH oxidase and the respiratory burst. Semin. Cell Biol., 1995, 6, 357-65.
95. Segal, A.W.; Abo, A. The biochemical basis of the NADPH oxidase of phagocytes. Trends Biochem. Sci., 1993, 18, 43-7
96. Babior, B.M.; Kipnes, R.S.; Curnutte, J.T. Biological defense mechanisms. The production by leukocytes of superoxide, a potential bactericidal agent. J. Clin. Invest., 1973, 52, 741-4.
97. Hancock, J.T.; Desikan, R.; Neill, S.J. Role of reactive oxygen species in cell signalling pathways. Biochem. Soc. Trans., 2001, 29, 345-50.
98. Kettle, A.J.; Winterbourn, C.C. Myeloperoxidase: A key regulator of neutrophil oxidant production. Redox Rep., 1997, 3, 3-15.
99. Van Dalen, C.J.; Whitehouse, M.W.; Winterbourn, C.C.; Kettle, A.J. Thiocyanate and chloride as competing substrates for myeloperoxidase. Biochem. J., 1997, 327, 487-92.
100. Koppenol, W.H. The centennial of the Fenton reaction. Free Radic. Biol. Med., 1993, 15, 645-51.
101. Qian, S.Y.; Buettner, G.R. Iron and dioxygen chemistry is an important route to initiation of biological free radical oxidations: An electron paramagnetic resonance spin trapping study. Free Radic. Biol. Med., 1999, 26, 1447-56.
102. ∞ free radicals. Photochem. Photobiol., 1978, 28, 645-9.
103. ∞ radicals in aqueous solution. J. Phys. Chem. Ref. Data, 1985, 14, 1041-1100.
104. Balogh, G.T.; Illés, J.; Székely, Z.; Forrai, E.; Gere, A. Effect of different metal ions on the oxidative damage and antioxidant capacity of hyaluronic acid. Arch. Biochem. Biophys., 2003, 410, 76-82.
105. Burkhardt, H.; Schwingel, M.; Menninger, H.; Macartney, H.W.; Tschesche, H. Oxygen radicals as effectors of cartilage destruction - Direct degradative effect on matrix components and indirect action via activation of latent collagenase from polymorphonuclear leukocytes. Arthritis Rheum., 1986, 29, 379-87.
106. Gao, F.; Koenitzer, J.R.; Tobolewski, J.M.; Jiang, D.; Liang, J.; Noble, P.W.; Oury, T.D. Extracellular superoxide dismutase inhibits inflammation by preventing oxidative fragmentation of hyaluronan. J. Biol. Chem., 2008, 283, 6058-66.
107. Rees, M.D.; Hawkins, C.L.; Davies, M.J. Hypochlorite and superoxide radicals can act synergistically to induce fragmentation of hyaluronan and chondroitin sulphates. Biochem. J., 2004, 381, 175-84.
108. Koppenol, W.H. Thermodynamics of reactions involving oxyradicals and hydrogen peroxide. Bioelectrochem. Bioenerg., 1987, 18, 3-11.
109. Yamazaki, K.; Fukuda, K.; Matsukawa, M.; Hara, F.; Yoshida, K.; Akagi, M.; Munakata, H.; Hamanishi C. Reactive oxygen species depolymerize hyaluronan: Involvement of the hydroxyl radical. Pathophysiology, 2003, 9, 215-20.
110. Mendoza, G.; Alvarez, A.I.; Pulido, M.M.; Molina, A.J.; Merino, G.; Real, R.; Fernandes, P.; Prieto, J.G. Inhibitory effects of different antioxidants on hyaluronan depolymerization. Carbohydr. Res., 2007, 342, 96-102.
111. Schiller, J.; Fuchs, B.; Arnold, K. The molecular organization of polymers of cartilage in health and disease. Curr. Org. Chem., 2006, 10, 1771-89.
112. Roberts, C.R.; Roughley, P.J.; Mort, J.S. Degradation of human proteoglycan aggregate induced by hydrogen peroxide. Protein fragmentation, amino acid modification and hyaluronic acid cleavage. Biochem. J., 1989, 259, 805-11.
113. Lüsse, S.; Knauss, R.; Werner, A.; Gründer, W.; Arnold, K. Action of compression and cations on the proton and deuterium relaxation in cartilage. Magn. Reson. Med., 1995, 33, 483-9
114. Schiller, J.; Arnhold, J.; Schwinn, J.; Sprinz, H.; Brede, O.; Arnold, K. Reactivity of cartilage and selected carbohydrates with hydroxyl radicals: An NMR study to detect degradation products. Free. Radic. Res., 1998, 28, 215-28.
115. Kowanko, I.C.; Bates, E.J.; Ferrante, A. Mechanisms of human neutrophil-mediated cartilage damage in vitro: The role of lysosomal enzymes, hydrogen peroxide and hypochlorous acid. Immunol. Cell Biol., 1989, 67, 321-9.
116. ∞NO: How far can either radical, or any specific reaction product, transmit a message under in vivo conditions? Chem. Biol. Interact., 1994, 90, 35-45.
117. Cadenas, E. Biochemistry of oxygen toxicity. Annu. Rev. Biochem., 1989, 58, 79-110.
118. von Sonntag, C. The chemical basis of radiation biology, Taylor & Francis: London, 1984.
119. Deeble, D.J.; Bothe, E.; Schuchmann, H.-P.; Parsons, B.J.; Phillips, G.O.; von Sonntag, C. The kinetics of hydroxyl-radical-induced strand breakage of hyaluronic acid. A pulse radiolysis study using conductometry and laser-light-scattering. Z. Naturforsch., 1990, 45c, 1031-43.
120. Gutteridge, J.M.C.; Rowley, D.A.; Halliwell, B. Superoxidedependent formation of hydroxyl radicals in the presence of iron salts. Detection of "free" iron in biological systems by using bleomycin-dependent degradation of DNA. Biochem. J., 1981, 199, 263-5.
121. Lath D.; Csomorová K.; Kolláriková G.; Stankovská M.; Šoltés L.: Molar mass-intrinsic viscosity relationship of high-molar-mass hyaluronans: Involvement of shear rate. Chem. Pap., 2005, 59, 291-293.
122. Šoltés L.; Mendichi R.; Kogan G.; Schiller J.; Stankovská M.; Arnhold J. Degradative action of reactive oxygen species on hyaluronan. Biomacromolecules, 2006, 7, 659-668.
123. Hawkins, C.L.; Davies, M.J. Direct detection and identification of radicals generated during the hydroxyl radical-induced degradation of hyaluronic acid and related materials. Free Radic. Biol. Med., 1996, 21, 275-90.
124. Morris, J.C. Acid ionization constant of HOCl from 5 to 35 degrees. J. Phys. Chem., 1966, 70, 3798-3801.
125. Schiller, J.; Arnhold, J.; Gründer, W.; Arnold, K. The action of hypochlorous acid on polymeric components of cartilage. Biol. Chem. Hoppe Seyler, 1994, 375, 167-72.
126. 13C NMR spectroscopy. Z. Naturforsch., 1995, 50c, 721-8.
127. Hawkins, C.L.; Davies, M.J. Degradation of hyaluronic acid, poly-and monosaccharides, and model compounds by hypochlorite: Evidence for radical intermediates and fragmentation. Free Radic. Biol. Med., 1998, 24, 1396-410.
128. Schiller, J.; Arnhold, J.; Sonntag, K.; Arnold, K. NMR studies on human, pathologically changed synovial fluids: Role of hypochlorous acid. Magn. Reson. Med., 1996, 35, 848-53.
129. Baker, M.S.; Green, S.P.; Lowther, D.A. Changes in the viscosity of hyaluronic acid after exposure to a myeloperoxidase-derived oxidant. Arthritis Rheum., 1989, 32, 461-7.
130. Stankovská, M.; Arnhold, J.; Rychlý, J.; Spalteholz, H.; Gemeiner, P.; Šoltés, L. In vitro screening of the action of non-steroidal anti-inflammatory drugs on hypochlorous acid-induced hyaluronan deg-radation. Polym. Degrad. Stabil., 2007, 92, 644-652.
131. Katrantzis, M.; Baker, M.S.; Handley, C.J.; Lowther, D.A. The oxidant hypochlorite (OCl-), a product of the myeloperoxidase system, degrades articular cartilage proteoglycan aggregate. Free Radic Biol Med., 1991, 10, 101-9.
132. Henrotin, Y.E.; Bruckner, P.; Pujol, J.P. The role of reactive oxygen species in homeostasis and degradation of cartilage. Osteoarthritis Cartilage, 2003, 11, 747-55.
133. Knott, A.B.; Bossy-Wetzel, E. Nitric oxide in health and disease of the nervous system. Antioxid. Redox Signal., 2008, in press.
134. Stefanovic-Racic, M.; Stadler, J.; Evans, C.H. Nitric oxide and arthritis. Arthritis Rheum., 1993, 36, 1036-44
135. Nauser, T.; Koppenol, J. The rate constant of the reaction of superoxide with nitrogen monoxide: Approaching the diffusion limit. J. Phys. Chem. A, 2002, 106, 4084-86.
136. Hrabarová E.; Gemeiner P.; Šoltés L. Peroxynitrite: In vivo and in vitro synthesis and oxidant degradative action on biological systems regarding biomolecular injury and inflammatory processes. Chem. Pap., 2007, 61, 417-437.
137. Li, M.; Rosenfeld, L.; Vilar, R.E.; Cowman, M.K. Degradation of hyaluronan by peroxynitrite. Arch. Biochem. Biophys., 1997, 341, 245-50.
138. Stankovská, M.; Hrabárová, E.; Valachová, K.; Molnárová, M.; Gemeiner, P.; Šoltés, L. The degradative action of peroxynitrite on high-molecular-weight hyaluronan. Neuro Endocrinol. Lett., 2006, 27 (Suppl 2), 31-34.
139. Kennett, E.C.; Davies, M.J. Degradation of matrix glycosaminoglycans by peroxynitrite/peroxynitrous acid: Evidence for a hydroxyl-radical-like mechanism. Free Radic. Biol. Med., 2007, 42, 1278-89.
140. Al-Assaf, S.; Navaratnam, S.; Parsons, B.J.; Phillips, G.O. Chain scission of hyaluronan by peroxynitrite. Arch. Biochem. Biophys., 2003, 411, 73-82.
141. Corsaro, M.M.; Pietraforte, D.; Di Lorenzo, A.S.; Minetti, M.; Marino, G. Reaction of peroxynitrite with hyaluronan and related saccharides. Free Radic. Res., 2004, 4, 343-53.
142. Guiraud, H.J.; Foote, C.S. Chemistry of superoxide ion. 3. Quenching of singlet oxygen. J. Am. Chem. Soc., 1976, 98, 1984-86.
143. Connor, J.R.; Manning, P.T.; Settle, S.L.; Moore, W.M.; Jerome, G.M.; Webber, R.K.; Tjoeng, F.S.; Currie, M.G. Suppression of adjuvant-induced arthritis by selective inhibition of inducible nitric oxide synthase. Eur. J. Pharmacol., 1995, 273, 15-24.
144. Lapĉík, L.; Schurz, J. Photochemical degradation of hyaluronic acid by singlet oxygen. Biopolymers, 1991, 31, 1429.
145. Scott, J.E. Supramolecular organization of extracellular matrix glycosaminglycans, in vitro and in the tissues. FASEB J., 1992, 6, 2639-45.
146. Hlavacek, M. The role of synovial fluid filtration by cartilage in lubrication of synovial joints: I. Mixture model of synovial fluid. J. Biomechanics, 1993, 26, 1145-50.
147. Swann, D.A.; Radin, L. Molecular basis of articular lubrication: 1. Purification and properties of lubricating fraction from bovine synovial fluid. J. Biol. Chem., 1972, 247, 8069-73.
148. 1H-NMR spectroscopy. Int. J. Biol. Macromol., 1994, 16, 237-44.
149. Camenisch, T.; Spicer, A.P.; Brehm-Gibson, T.; Biesterfeldt, J.; Augustine, M.L.; Calabro, A. Jr; Kubalak, S.; Klewer, S.E.; McDonald, J.A. Disruption of hyaluronan synthase-2 abrogates normal cardiac morphogenesis and hyaluronan-mediated transformation of epithelium to mesenchyme. J. Clin. Invest., 2000, 106, 349-60
150. Mjaatvedt, C.H.; Yamamura, H.; Capehart, A.A.; Turner, D.; Markwald, R.R. The Cspg2 gene, disrupted in the hdf mutant, is required for right cardiac chamber and endocardial cushion formation. Dev. Biol., 1998, 202, 56-66.
151. Yamamura, H.; Zhang, M.; Markwald, R.R.; Mjaatvedt, C.H. A heart segmental defect in the anterior-posterior axis of a transgenic mutant mouse. Dev. Biol., 1997, 186, 58-72.
152. Zhuo, L.; Yoneda, M.; Zhao, M.; Yingsung, W.; Yoshida, N.; Kitagawa, Y.; Kawamura, K.; Suzuki, T.; Kimatam K. Defect in SHAP-hyaluronan complex causes severe female infertility. A study by inactivation of the bikunin gene in mice. J. Biol. Chem., 2001, 276, 7693-6
153. Termeer, C.; Benedix, F.; Sleeman, J.; Fieber, C.; Voith, U.; Ahrens, T.; Miyake, K.; Freudenberg, M.; Galanos, C.; Simon, J.C. Oligosaccharides of hyaluronan activate dendritic cells via toll-like receptor 4. J. Exp. Med., 2002, 195, 99-111.
154. Turley, E.A.; Noble, P.W.; Bourguignon, L.Y. Signaling properties of hyaluronan receptors. J. Biol. Chem., 2002, 277, 4589-92.
155. Markwald, R.R.; Krook, J.M.; Kitten, G.T.; Runyan, R.B. Endocardial cushion tissue development: Structural analyses on the attachment of extracellular matrix to migrating mesenchymal cell surfaces. Scan. Electron. Microsc., 1981, 2, 261-274.
156. Bernanke, D.H.; Markwald, R.R. Effects of hyaluronic acid on cardiac cushion tissue cells in collagen matrix cultures. Tex. Rep. Biol. Med., 1979, 39, 271-85.
157. Baldwin, H.S.; Lloyd, T.R.; Solursh, M. Hyaluronate degradation affects ventricular function of the early postlooped embryonic rat heart in situ. Circ. Res., 1994, 74, 244-252.
158. Ferencz, C.; Boughman, J.A. Congenital heart disease in adolescents and adults. Teratology, genetics, and recurrence risks. Cardiol. Clin., 1993, 11, 557-567.
159. Pierpont, M.E.; Markwald, R.R.; Lin, A.E. Genetic aspects of atrioventricular septal defects. Am. J. Med. Genet., 2000, 97, 289-296.
160. Salustri, A.; Camaioni, A.; Di Giacomo, M.; Fulop, C.; Hascall, V.C. Hyaluronan and proteoglycans in ovarian follicles. Hum. Reprod. Update, 1999, 5, 293-301.
161. Talbot, P. Sperm penetration through oocyte investments in mammals. Am. J. Anat., 1985, 174, 331-346.
162. Chen, L.; Russell, P.T.; Larsen, W.J. Functional significance of cumulus expansion in the mouse: Roles for the preovulatory synthesis of hyaluronic acid within the cumulus mass. Mol. Reprod. Dev., 1993, 34, 87-93.
163. Aitken, R.J.; Bowie, H.; Buckingham, D.; Harkiss, D.; Richardson, D.W.; West, K.M. Sperm penetration into a hyaluronic acid polymer as a means of monitoring functional competence. J. Androl., 1992, 13, 44-54.
164. Lin, Y, Mahan, K.; Lathrop, W.F.; Myles, D.G.; Primakoff, P. Hyaluronidase activity of the sperm plasma membrane protein PH-20 enables sperm to penetrate the cumulus cell layer surrounding the egg. J. Cell Biol., 1994, 125, 1157-1163.
165. Margolis, R.K.; Crockett, C.P.; Kiang, W.L.; Margolis, R.U. Glycosaminoglycans and glycoproteins associated with rat brain nuclei. Biochim. Biophys. Acta, 1976, 451, 465-469.
166. Day, A.J.; Prestwich, G.D. Hyaluronan-binding proteins: Tying up the giant. J. Biol. Chem., 2002, 277, 4585-4588.
167. Assmann, V.; Marshall, J.F.; Fieber, C.; Hofmann, M.; Hart, I.R. The human hyaluronan receptor RHAMM is expressed as an intracellular protein in breast cancer cells. J. Cell. Sci., 1998, 111, 1685-1694.
168. Huang, L.; Grammatikakis, N.; Yoneda, M.; Banerjee, S.D.; Toole, B.P. Molecular characterization of a novel intracellular hyaluronanbinding protein. J. Biol. Chem., 2000, 275, 29829-29839
169. Turley, E.A.; Noble, P.W.; Bourguignon, L.Y. Signaling properties of hyaluronan receptors. J. Biol. Chem., 2002, 277, 4589-4592.
170. Evanko, S.P.; Wight, T.N. Intracellular localization of hyaluronan in proliferating cells. J. Histochem. Cytochem., 1999, 47, 1331-1342.
171. Maxwell, C.A.; Keats, J.J.; Crainie, M.; Sun, X.; Yen, T.; Shibuya, E.; Hendzel, M.; Chan, G.; Pilarski, L.M. RHAMM is a centrosomal protein that interacts with dynein and maintains spindle pole stability. Mol. Biol. Cell, 2003, 14, 2262-2276.
172. Aridor, M.; Balch, W.E. Integration of endoplasmic reticulum signaling in health and disease. Nat. Med., 1999, 5, 745-751.
173. Kaufman, R.J. Stress signaling from the lumen of the endoplasmic reticulum: Coordination of gene transcriptional and translational controls. Genes Dev., 1999, 13, 1211-1233.
174. Ron, D. Translational control in the endoplasmic reticulum stress response. J. Clin. Invest., 2002, 110, 1383-1388
175. Teder, P.; Vandivier, R.W.; Jiang, D.; Liang, J.; Cohn, L.; Pure, E.; Henson, P.M.; Noble, P.W. Resolution of lung inflammation by CD44. Science, 2002, 296, 155-158.
176. Folkman, J. Tumour angiogenesis. Adv. Cancer Res., 1985, 43, 175-203.
177. Folkman, J.; Shing, Y. Angiogenesis. J. Biol. Chem., 1992, 267, 10931-4.
178. Craft, P.S.; Harris, A.L. Clinical prognostic significance of tumour angiogenesis. Ann. Oncol. 1994, 5, 305-312.
179. Li, V.W.; Folkerth, R.D.; Watanabe, H.; Yu, C.; Rupnick, M.; Barnes, P.; Scott, P.; Black, M.L.; Sallen, S.E.; Folkman, J. Microvessel count and cerebrospinal fluid basic FGF in children with brain tumours. Lancet, 1994, 344, 82-86.
180. Bicknell, R.; Harris, A.L. Novel growth-regulatory factors and tumour angiogenesis. Eur. J. Cancer, 1991, Suppl. 27, 781-4.
181. Denekamp, J. Angiogenesis, neovascular proliferation and vascular pathophysiology as targets for cancer therapy. Brit. J. Radiol., 1993, 66, 181-96.
182. Stokes, C.L.; Lauffenburger, D.A. Analysis of the roles of microvessel endothelial-cell random motility and chemotaxis in angiogenesis. J. Theor. Biol., 1991, 152, 377-403.
183. Knighton, D.; Ausprunk, D.; Tapper, D.; Folkman, J. Avascular and vascular phases of tumor growth in the chick embryo. Brit. J. Cancer, 1997, 130, 257-263.
184. Folkman, J.; Klagsbrun, M. Angiogenic factors. Science, 1987, 235, 442-447.
185. Rooney, P.; Kumar, S.; Ponting, J; Wang; M. The role of hyaluronan in tumour neovascularization. Int. J. Cancer, 1995, 60, 632-6.
186. West, D.C.; Hampson, I.N.; Arnold, F.; Rumar, S. Angiogenesis induced by degradation products of hyaluronic acid. Science, 1985, 228, 1324-6.
187. Sattar, A.; Rooney, P.; Kumar, S.; Pye, D.; West, D.C.; Scott, I.; Ledger, P. Application of angiogenic oligosaccharides of hyaluronan increase blood-vessel numbers in skin. J. Invest. Dermatol., 1994, 103, 576-9.
188. Losa, G.A.; Alini, M. Sulfated proteoglycans in the extracellular matrix of human breast tissues with infiltrating carcinoma. Int. J. Cancer, 1993, 54, 552-57.
189. Iozzo, R.V. Biology of disease. Proteoglycans, structure, function and role in neoplasia. Lab. Invest., 1985, 53, 373-96
190. Boudreau, N.; Turlev, E.; Rabinovitch, M. Fibronectin, hyaluronan and a hyaluronan-binding protein contribute to increased ductus arteriosus smooth-muscle-cell migration. Devel. Biol., 1991, 143, 235-47.
191. Maragoudakis, M.E.; Missirlis, E.; Karakiulakis, G.; Bastiki, M.; Isopanoglou, N. Basement-membrane biosynthesis as a target for developing inhibitors of angiogenesis with anti-tumour activity. Int. J. Radiol. Biol., 1991, 60, 54-9.
192. Toole, B.P. Hyaluronan and its binding proteins, the hyaladherins. Curr. Opin. Cell Biol., 1990, 2, 839-44.
193. Curran, T.; Pranza, B.R. Fos and jun: The AP-1 connection. Cell, 1988, 55, 395-7.
194. Miodonski, A.; Kus, J.; Olszewski, E.; Tyronkiewicz, R. Scanning electron microscopic studies on blood vessels. Arch. Otolaryngol., 1980, 106, 321-32.
195. Tammi, R.H.; Kultti, A.; Kosma, V.M.; Pirinen, R.; Auvinen, P.; Tammi, M.I. Hyaluronan in human tumors: Pathobiological and prognostic messages from cell-associated and stromal hyaluronan. Semin. Cancer Biol., 2008, 18, 288-95.
196. Pienimaki, J.P.; Rilla, K.; Fulop, C, Sironen, R.K.; Karvinen, S.; Pasonen, S.; Lammi, M.J.; Tammi, R.; Hascall, V.C.; Tammi, M.I. Epidermal growth factor activates hyaluronan synthase 2 in epidermal keratinocytes and increases pericellular and intracellular hyaluronan. J. Biol. Chem., 2001, 276, 20428-35.
197. Knudson, W.; Toole, B.P. Membrane association of the hyaluronate stimulatory factor from LX-1 human lung carcinoma cells. J. Cell Biochem., 1988, 38, 165-77.
198. Edward, M.; Gillan, C.; Micha, D.; Tammi, R.H. Tumour regulation of fibroblast hyaluronan expression: A mechanism to facilitate tumour growth and invasion. Carcinogenesis, 2005, 26, 1215-23.
199. Stern, R. Hyaluronan metabolism: A major paradox in cancer biology. Pathol. Biol. (Paris), 2005, 53, 372-82.
200. Knudson, W.; Chow, G.; Knudson, C.B. CD44-mediated uptake and degradation of hyaluronan. Matrix Biol., 2002, 21, 15-23.
201. Tuhkanen, H.; Anttila, M.; Kosma, V.M.; Yla-Herttuala, S.; Heinonen, S.; Kuronen. A.; Juhola, M.; Tammi, R.; Tammi, M.; Mannermaa, A. Genetic alterations in the peritumoral stromal cells of malignant and borderline epithelial ovarian tumors as indicated by allelic imbalance on chromosome 3p. Int. J. Cancer, 2004, 109, 247-52
202. Shiedlin, A.; Bigelow, R.; Christopher, W.; Arbabi, S.; Yang, L.; Maier, R.V.; Wainwright, N.; Childs, A.; Miller, R.J. Evaluation of hyaluronan from different sources: Streptococcus zooepidemicus, rooster comb, bovine vitreous, and human umbilical cord. Biomacromolecules, 2004, 5, 2122-7.
203. DeAngelis, P.L.; Weigel, P.H. Immunochemical confirmation of the primary structure of streptococcal hyaluronan synthase and synthesis of high molecular weight product by the recombinant enzyme. Biochemistry, 1994, 33, 9033-9.
204. Widner, B.; Behr, R.; Von Dollen, S.; Tang, M.; Heu, T.; Sloma, A.; Sternberg, D.; DeAngelis, P.L.; Weigel, P.H.; Brown, S. Hyaluronic acid production in Bacillus subtilis. Appl. Environ. Microbiol., 2005, 71, 3747-52.
205. Rychlý J.; Šoltés L.; Stankovská M.; Janigová I.; Csomorová K.; Sasinková V.; Kogan G.; Gemeiner P. Unexplored capabilities of chemiluminescence and thermoanalytical methods in characterization of intact and degraded hyaluronans. Polym. Degrad. Stabil., 2006, 91, 3174-84.
206. Mendichi, R.; Soltés, L. Hyaluronan molecular weight and polydispersity in some commercial intra-articular injectable preparations and in synovial fluid Inflamm. Res., 2002, 51, 115-6.
207. Balazs, E.A. Ultrapure hyaluronic acid and the use thereof. U.S. Pat. No. 4,141,973, 1973.
208. Filion, M.C.; Phillips, N.C. In Hyaluronan-cemical, biochemical and biological aspects; Kennedy, J.F.; Phillips, G.O.; Williams, P.A.; Hascall, V.C.; Eds. Woodhead Publishing Ltd. Abington Hall: Abington, 2002, pp. 428-434.
209. Kendall, F.E.; Heidelberger, M.; Dawson, M.F. A serologically inactive polysaccharide elaborated by mucoid strains of group A hemolytic streptococcus. J. Biol. Chem., 1937, 118, 61-9.
210. Bisno, A.L.; Brito, M.O.; Collins, C.M. Molecular basis of group A streptococcal virulence. Lancet Infect. Dis., 2003, 3, 191-200.
211. Gerlach, D.; Köhler, W. Production and isolation of streptococcal hyaluronic acid. Zentralbl. Bakteriol., 1970, 215, 187-9.
212. Mendichi, R.; Schieroni, A.G. Fractionation and characterization of ultra-high molar mass hyaluronan: 2. On-line size exclusion chromatography methods. Polymer, 2002, 43, 6115-121.
213. Kyselová, Z.; tefek, M.; Bauer, V. J. Diabetes Complications, 2004, 18, 129-40.
214. Kyselová, Z.; Gajdošík, A.; Gajdošíková, A.; Uličná, O.; Mihálová, D.; Karasu, C.; tefek, M. Effect of the pyridoindole antioxidant stobadine on development of experimental diabetic cataract and on lens protein oxidation in rats: Comparison with vitamin E and BHT. Mol. Vis., 2005, 11, 56-65.
215. American College of Rheumatology, Subcommittee on Osteoarthritis Guidelines. Recommendations for the medical management of osteoarthritis of the hip and knee: 2000 update. Arthritis Rheum. 2000, 43, 1905.
216. George, E. Intra-articular hyaluronan treatment for osteoarthritis. Ann. Rheum. Dis., 1998, 57, 637-40.
217. Balazs, E.A.; Denlinger, J.L. Viscosupplementation: A new concept in the treatment of osteoarthritis. J. Rheumatol., 1993, 39, 3-9.
218. Simon, L.S.: Viscosupplementation therapy with intra-articular hyaluronic acid. Fact or fantasy? Rheum. Dis. Clin. North. Am., 1999, 25, 345-57.
219. Soltés, L.; Steiner, B.; Machová, E.; Kogan, G.; Bystrický, S.; Mendichi, R.; Bauer, V.; Mach, M.; Alföldi, J.; Stratilová, E. Method of preparation of ultra-high molecular-weight hyaluronans. Slovak Patent No. 282717.
220. Soltés, L.; Steiner, B.; Machová, E.; Kogan, G.; Bystrický, S.; Mendichi, R.; Bauer, V.; Mach, M.; Alföldi, J.; Stratilová, E. Clathrate complexes formed by hyaluronic acid derivatives and use thereof as pharmaceuticals. EP1272530B1, AU2001252180B2, 2006.
221. Soltés, L.; Mendichi, R.; Kogan, G.; Mach, M. Associating hyaluronan derivatives: A novel horizon in viscosupplementation of osteoarthritic joints. Chem. Biodivers., 2004, 1, 468-472.
222. Soltés, L.; Mendichi, R.; Machová, E.; Steiner, B.; Alföldi, J.; Sasinková, V.; Bystrický, S.; Balog, K. Cyclodextrin derivative of hyaluronan. Carbohydr. Polym., 1999, 39, 17-24.
223. De Luca, G.; Renier, D.; Kirschner, G. clathrate Complexes Formed by Hyaluronic Acid Derivatives, CRS Workshop "Ciclodestrine, proprietà e applicazioni", Padua, Italy, November 29-30, 2002.
224. Misloviĉová, D.; Kogan, G.; Gosselet, N.M.; Sébille, B.; Šoltés L. Controlling the association of adamantyl-substituted poly{N-[tris(hydroxymethyl)methyl]acrylamide} and a beta-cyclodextrin/epichlorohydrin polymer by a small drug molecule-naproxen. Chem. Biodivers., 2007, 4, 52-57.
225. Charlot, A.; Heyraud, A.; Guenot, P.; Rinaudo, M.; Auzély-Velty, R. Controlled synthesis and inclusion ability of a hyaluronic acid derivative bearing beta-cyclodextrin molecules. Biomacromolecules, 2006, 7, 907-913.
226. Siegelman, M.H.; DeQrendele, H.C.; Estess, P. Activation and interaction of CD44 and hyaluronan in immunological systems. J. Leukoc. Biol., 1999, 66, 315-321.
227. Toole, B.P. Hyaluronan. In Iozzo, R.V. Proteoglycans, Structure, Biology, and Molecular Interactions. 2000, Chapter 4, 61-92. New York, Basel, Marcel Dekker.
228. Fujii, K.; Tanaka, Y.; Hubscher, S.; Saito, K.; Ota, T.; Eto, S. Cross-linking of CD44 on rheumatoid synovial cells up-regulates VCAM-1. J. Immunol., 1999, 162, 2391-2398.
229. Ishida, O.; Tanaka, Y.; Morimoto, L.; Takigawa, M.; Eto, S. Chondrocytes are regulated by cellular adhesion through CD44 and hyaluronic acid pathway. J. Bone Miner Res., 1997, 12, 1657-1663
230. Ghosh, P.; Guidolin, D. Potential mechanism of action of intraarticular hyaluronan therapy in osteoarthritis: Are the effects molecular weight dependent? Semin. Arthritis Rheum., 2002, 32, 10-37.
231. Lee, J.Y.; Spicer, A.P. Hyaluronan: A multifunctional, megaDalton, stealth molecule. Curr. Opin. Cell Biol., 2000, 12, 581-586.
232. Ohkawara, Y.; Tamura, G.; Iwasaki, T.; Tanaka, A.; Kikuchi, T.; Shirato, K. Activation and transforming growth factor beta production in eosinophils by hyaluronan. Am. J. Respir. Cell Mol. Biol., 2000, 23, 444-451.
233. Forrester, J.V.; Wilkinson, P.C. Inhibition of leucocyte locomotion by hyaluronic acid. J. Cell Sci., 1981, 48, 315-331.
234. Partsch, G.; Schwarzer, C.; Neumuller, J.; Dunky, A.; Petera, P.; Bröll, H.; Ittner, G.; Jantsch, S. Modulation of the migration and chemotaxis of PMN cells by hyaluronic acid. Z. Rheumatol., 1989, 48, 123-128.
235. Peluso, G.P.; Perbellini, A.; Tajana, G.F. The effect of high and low molecular weight hyaluronic acid on mitogen-induced lymphocyte proliferation. Curr. Ther. Res., 1990, 47, 437-443.
236. Smith, M.M.; Ghosh, P. The synthesis of hyaluronic acid by human synovial fibroblasts is influenced by the nature of the hyaluronate in the extracellular environment. Rheumatol. Int., 1987, 7, 113-122.
237. 2 induction by interteukin-1 in rabbit articular chondrocytes. Agents Actions 1993, 38, 122-125.
238. Fukuda, K.; Dan, H.; Takayama, M.; Kumano, F.; Saitoh, M.; Tanaka, S. Hyaluronic acid increases proteoglycan synthesis in bovine articular cartilage in the presence of interleukin-1. J. Pharmacol. Exp. Ther., 1996, 277, 1672-1675.
239. Brew, K.; Dinakarpandian, D.; Nagase, H. Tissue inhibitors of metalloproteinases: Evolution, structure and function. Biochim. Biophys. Acta, 2000, 1477, 267-283.
240. Yasui, T.; Akatsuka, M.; Tobetto, K.; Umemoto, J.; Ando, T.; Yamashita, K. Effects of hyaluronan on the production of stromelysin and tissue inhibitor of metalloproteinase-1 (TlMP-1) in bovine articular chondrocytes. Biomed. Res., 1992, 13, 343-348.
241. Takahashi, K.; Hashimoto, S.; Kubo, T.; Hirasawa, Y.; Lotz, M.; Amiel, D. Effect of hyaluronan on chondrocyte apoptosis and nitric oxide production in experimentally induced osteoarthritis. J. Rheumatol., 2000, 27, 1713-1720.
242. Lisiglioli, G.; Grassi, F.; Zini, N.; Toneguzzi, S.; Piacentini, A.; Guidolin, D.; Bevilacqua, C.; Facchini, A. Anti-FAS-induced apoptosis in chondrocytes reduced by hyaluronan. Evidence for CD44 and CD54 (intercellular adhesion molecule 1) involvement. Arthritis Rheum., 2001, 44, 1800-1807.
243. Homandberg, G.A.; Hui, F. Association of proteoglycan degradation with catabolic cytokine and stromelysin release from cartilage cultured with fibronectin fragments. Arch. Biochem. Biophys., 1996, 334, 325-331.
244. Ialenti, A.; Di Rosa, M. Hyaluronic acid modulates acute and chronic inflammation. Agents Actions, 1994, 43, 44-47.
245. Abatangelo, G.; Botti, P.; Del Bue, M.; Gei, G.; Samson, J.C.; Cortivo, R.; De Galateo, A.; Martelli, M. Intraarticular sodium hyaluronate injections in the Pond-Nuki experimental-model of osteoarthritis in dogs. I: Biochemical results. Clin. Orthop. Relat. Res., 1989, 241, 278-285.
246. Smith, G.N.; Mickler, E.A.; Myers, S.L.; Brandt, K.D. Effect of intraarticular hyaluronan injection on synovial fluid hyoluronan in thu early stage of canine post-traumatic osteoarthritis. J. Rheumatol., 2001, 28, 1341-1346.
247. Asari, A.; Miyauchi, S.; Matsuzaka, S.; Ito, T.; Kominami, E.; Uchiyama, K. Molecular weight-dependent effects of hyaluronate on the arthritic synovium. Arch. Histol. Cytol., 1998, 61, 125-135
248. Ghosh, P.; Read, R.; Armstrong, S.; Wilson, D.; Marshall, R.; McNair, P. The effects of intraarticular administration of hyaluronan in a model of early osteoarthritis in sheep. I. Gait analysis and radiological and morphological studies. Semin. Arthritis Rheum., 1993, 22(6 Suppl. 1), 18-30.
249. Ghosh, P.; Read, R.; Numata, Y.; Smith, S.; Armstrong, S.; Wilson, D. The effects of intraarticular administration of hyaluronan in a model of early osteoarthritis in sheep. II. Cartilage composition and proteoglycan metabolism. Semin. Arthritis Rheum., 1993, 22(6 Suppl. 1), 31-42.
250. Ghosh, P.; Holbert, C.; Read, R.; Armstrong, S. Hyaluronic acid (hyaluronan) in experimental osteoarthritis. J. Rheumatol. Suppl., 1995, 43, 155-7.
251. Neo, H.; Ishimaru, J.I.; Kurita, K.; Goss, A.N. The effect of hyaluronic acid on experimental temporomandibular joint osteoarthrosis in the sheep. J. Oral Maxillofac. Surg., 1997, 55, 1114-.
252. Smith, M.M.; Cake, M.A.; Ghosh, P.; Schiavinato, A.; Read, R.A.; Little, C.B. Significant synovial pathology in a meniscectomy model of osteoarthritis: Modification by intra-articular hyaluronan therapy. Rheumatology, 2008, 47, 1172-8.
253. Aggarwal, A.; Sempowski, I.P. Hyaluronic acid injections for knee osteoarthritis. Systematic review of the literature. Can. Fam. Physician., 2004, 50, 249-56.